Schedule 13G ownership disclosure

INTEC PHARMA LTD JERUSALEM

Security class unavailable · CUSIP: M53644148

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
197,016
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000007
Form type
SC 13G/A
Filer
Intec Pharma Ltd.
CIK
CIK 1638381
Filed
Jan 04, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub